Plain-English translation of NCT07682610 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a system called QUILS™ (Quality Implementation of Lung Screening) can help lung cancer screening programs across Kentucky work better and reach more people who need screening. Kentucky has already done remarkably well at catching lung cancer early — better than most other states — and this study aims to make that success even stronger by spreading proven best practices to all screening programs.
Kentucky is a leader in catching lung cancer early through screening, but not everyone who needs screening has access to it yet. This trial exists to help screening programs share what works best so more people at risk can benefit from early detection.
You likely qualify if…
You likely don't qualify if…
If you work at a participating lung cancer screening program, you would complete a survey assessing your current practices, attend presentations where you receive feedback on your program's performance, and take part in interviews about your experiences. You would also gain access to resources and help creating an action plan to improve your program. This is a collaborative process designed to help your screening team learn from best practices used by other programs.
AI-generated summary from trial data · Aug 14, 2026 · Not medical advice
United States